Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 740-uterine-and-adnexa-procedures-for-non-ovarian-and-non-adnexal-malignancy-with-cc
    Ask Trek AI about this page

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    DRG 740 addresses inpatient uterine and adnexa procedures for non-ovarian and non-adnexal malignancy when a Complication or Comorbidity is present; it defines the clinical scope and case mix for payment. Correct specification of procedures and Complication or Comorbidity documentation matters for inpatient reimbursement under Centers for Medicare & Medicaid Services rules.

    Customize your policy alerts

    Sign up for drg 740 policy alerts

    Get alerted when payer policies referencing 740 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 740 Overview

    DRG 740 covers inpatient admissions for uterine and adnexa surgical procedures performed for non-ovarian and non-adnexal malignancy when the record includes a documented Complication or Comorbidity. This Diagnosis-Related Group is focused on procedures such as hysterectomy and related resection of uterine or fallopian tube structures where a Complication or Comorbidity increases clinical complexity. It matters for Medicare payment because the presence of a Complication or Comorbidity shifts resource intensity and reimbursement relative to cases without such comorbid conditions. Accurate coding of the principal procedure and all relevant diagnoses determines appropriate Medicare Severity Diagnosis-Related Group assignment and payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative multimodal management trials comparing surgical approaches and enhanced recovery protocols for patients undergoing hysterectomy or adnexal surgery for uterine or other non-ovarian non-adnexal malignancies with significant comorbidity. These studies enroll hospitalized adults who require uterine or adnexal procedures and have complicating conditions (e.g., obesity, diabetes, cardiopulmonary disease) classified as complications or comorbidities (CC), and they test interventions such as minimally invasive versus open surgery pathways, anesthesia/analgesia bundles, and standardized perioperative care pathways. Results inform clinicians on reducing length of stay, complication rates, and resource use, and help payers evaluate which perioperative strategies are cost-effective for this higher-acuity DRG group.
    • Comparative effectiveness studies of adjuvant therapy sequencing and intraoperative decision tools for patients with uterine or other non-ovarian non-adnexal malignancy who require additional staging or cytoreductive procedures identified during the index admission. These trials or observational comparative cohorts focus on whether immediate extended surgery, staged procedures, or early initiation of adjuvant therapy impacts short-term surgical outcomes, readmission, and downstream oncologic outcomes for patients with CCs that increase perioperative risk. Findings are relevant to providers weighing operative extent against morbidity and to payers assessing downstream costs from readmissions, additional procedures, and long-term treatment pathways tied to decisions made during the inpatient episode.
    • Post-discharge outcomes and health services research tracking complications, functional recovery, and healthcare utilization in the 30–90 days after discharge for patients in this DRG, especially those with CC-driven increased risk of wound infection, thromboembolism, or hospital readmission. These prospective registries or pragmatic studies evaluate predictors of readmission, the effectiveness of transitional care interventions (telehealth follow-up, home health nursing, anticoagulation management), and total episode-of-care costs for this higher-acuity surgical cohort. Data guide hospitals and payers on targeted risk-reduction strategies, resource allocation for post-acute care, and reimbursement models that account for elevated post-discharge utilization in this group.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    744-D-C-CONIZATION-LAPAROSCOPY-AND-TUBAL-INTERRUPTION-WITH-CC-MCC

    D&C, Conization, Laparoscopy and Tubal Interruption with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.